AB
IMVT icon

Amalgamated Bank’s Immunovant IMVT Stock Holding History

Amalgamated Bank’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,203
Closed -$56K – 2203
2025
Q4 		$56K Buy
2,203
+193
+10% +$4.3K ﹤0.01% 1805
2025
Q3 		$32K Hold
2,010
– – ﹤0.01% 1970
2025
Q2 		$32K Hold
2,010
– – ﹤0.01% 1958
2025
Q1 		$34K Buy
2,010
+169
+9% +$3.54K ﹤0.01% 1891
2024
Q4 		$46K Hold
1,841
– – ﹤0.01% 1853
2024
Q3 		$52K Hold
1,841
– – ﹤0.01% 1835
2024
Q2 		$49K Hold
1,841
– – ﹤0.01% 1857
2024
Q1 		$59K Sell
1,841
-5,967
-76% -$218K ﹤0.01% 1827
2023
Q4 		$329K Sell
7,808
-93
-1% -$3.42K ﹤0.01% 1607
2023
Q3 		$303K Hold
7,901
– – ﹤0.01% 1624
2023
Q2 		$150K Buy
7,901
+3,221
+69% +$60.1K ﹤0.01% 1926
2023
Q1 		$73K Sell
4,680
-1,164
-20% -$20.2K ﹤0.01% 2161
2022
Q4 		$104K Buy
5,844
+764
+15% +$9.62K ﹤0.01% 2114
2022
Q3 		$28K Hold
5,080
– – ﹤0.01% 2709
2022
Q2 		$20K Sell
5,080
-863
-15% -$3.73K ﹤0.01% 2853
2022
Q1 		$33K Buy
+5,943
New +$37K ﹤0.01% 2643
2021
Q1 		– Sell
-5,841
Closed -$270K – 1609
2020
Q4 		$270K Buy
+5,841
New +$270K 0.01% 1282

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Amalgamated Bank's IMVT Position: Q1 2026 in Review

Amalgamated Bank sold out of Immunovant (IMVT) in Q1 2026, closing a stake of 2,203 shares — an estimated $56K sold.

Amalgamated Bank first reported a position in IMVT in Q4 2020 and held it in 17 quarters. The position peaked at $329K in Q4 2023. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Amalgamated Bank reported no remaining Immunovant position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 2,203 Immunovant shares in Q1 2026, an estimated $56K.
  • Amalgamated Bank first reported a position in Immunovant in Q4 2020 and held it in 17 quarters.
  • Amalgamated Bank's Immunovant position peaked at $329K in Q4 2023.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.